Production (Stage)
Cartesian Therapeutics, Inc.
RNAC
$10.34
$0.020.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.73% | 57.60% | -274.78% | 124.35% | 68.01% |
| Total Depreciation and Amortization | 137.86% | 69.93% | 45.92% | 7.10% | -32.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 112.93% | -134.65% | 227.19% | -92.36% | -70.20% |
| Change in Net Operating Assets | -203.43% | -73.47% | 180.46% | -403.66% | -62.89% |
| Cash from Operations | -230.02% | -151.14% | 194.77% | 9.24% | 31.65% |
| Capital Expenditure | -52.48% | 88.63% | -290.61% | -163.62% | -840.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -203.67% | 94.29% | -290.61% | -163.62% | -109.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.45% | -99.32% | 103,645.00% | -96.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | 97.53% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12,336.36% | -- | -- | -- | -- |
| Cash from Financing | -1,124.90% | -99.37% | 103,645.00% | -99.72% | 205.60% |
| Foreign Exchange rate Adjustments | 313.33% | 0.00% | -207.14% | 380.00% | -131.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -388.40% | -104.99% | 930.06% | -159.98% | 1,084.66% |